University of Minnesota. Driven to Discover.
Another American health worker has been infected with Ebola in West Africa's outbreak region.
With its Mar 7 launch date, the trial's main goal is to see if ring vaccination can knock down Ebola hot spots.
Steeply dropping cases, though, may cause the NIAID to vary from the original trial design.
The first batch of an experimental Ebola vaccine landed today in an outbreak country, with officials projecting a trial launch in Liberia within weeks.
The move comes a day after the DHS said travelers from outbreak nations would be funneled through 5 airports.
As West Africa cases top 8,000, the patient in Texas dies and the CDC announces airport screening steps.
Ebola cases are increasing exponentially in Liberia, where taxis might transmit disease.
The second American infected with Ebola returned home today, as new information emerged about experimental treatment use and more possible cases.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.